|
CDC OKs FluMist for 2018-19 Influenza Season
|
| |
|
In this Issue |
|
|
| • |
IVIG/Albumin Supply Index |
| • |
Open Market Pricing |
| • |
New Products from FFF |
| • |
Current Medicare
IVIG / SCIG Rates |
| • |
Resources |
| • |
Subscribe to IG Living and BioSupply Trends Quarterly |
|
|
|
|
|
|
| |
The Centers for Disease Control and Prevention advisory committee has voted 12-2 to recommend FluMist, the nasal spray version of the influenza vaccine, be used during the 2018-19 influenza season. [ read more ] |
|
SCIG Therapy Is Cost-Saving Versus IVIG in Canadian Study of Primary Immunodeficiency Patients
A first-ever prospective economic analysis by Canadian investigators found that, from both hospital- and health system-based perspectives, home-based subcutaneous immune globulin (SCIG) therapy was associated with significantly lower average total nondrug costs than hospital-based intravenous immune globulin (IVIG) therapy for patients with primary immunodeficiency disorders. [ read more ] |
|
Plasma Exchange with 5% Albumin Associated with Marked Stabilization of Brain Perfusion in Alzheimer's
Plasma exchange with 5% albumin replacement was associated with marked stabilization of brain perfusion in patients with mild to moderate Alzheimer's disease during a 21-week treatment period and reduced perfusion loss compared to control subjects at six-month follow-up. [ read more ]
|
|
With Snakebite Season in Summer, Medical Professionals Are Advised to Stock CroFab
Summer is snakebite season, and misunderstandings about proper treatment continue to subsist, not just among the general public, but among medical professionals as well. Only antivenoms can prevent or reverse most of the snakebite envenoming's effects, so it's important for healthcare facilities to have them in stock. Guidelines for stocking antivenom can be found at www.ncbi.nlm.nih.gov/pubmed/28669553 "In areas where snakebites are common, many, if not most, hospitals carry CroFab, which is used to treat pit viper bites. Pit vipers account for approximately 98 percent of bites from venomous snakes in the U.S., so it's important to have access to it," says Spencer Greene, MD, MS, FACEP, FACMT, director of the medical toxicology consultation services at Ben Taub General Hospital and Texas Children's Hospital, and a consulting toxicologist for the Southeast Texas Poison Center. [ read more ]
|
|
|
|
|
